A Sensational Development in the M&A Carousel: Rheinmetall, BASF and Lahontan Gold

Lahontan Gold: Preparing for a US IPO?

A small but strategically interesting acquisition is in the works in the gold sector. Lahontan Gold recently expanded its resource base and reaffirmed its goal of beginning construction of the Santa Fe mine as early as next year. Now comes the next step. The company plans to acquire Emergent Metals in its entirety, thereby expanding its position in the Walker Lane gold district in the US state of Nevada. Emergent shareholders will receive one Lahontan share for every 3.21 Emergent shares. This would represent a 47.8% premium over the 30-day average share price. Upon completion of the transaction, existing Lahontan shareholders would hold approximately 95.3% of the combined company. Strategically, this would allow Lahontan to control 100% of the West Santa Fe project while eliminating existing royalty payments on West Santa Fe and on the York claims within the Santa Fe project. In addition, the contiguous land package in Nevada expands to more than 93 km² through the adjacent New York Canyon project, located in likely one of the world’s best gold regions.

Financially, the acquisition will save Lahontan, among other things, future payments of about CAD 2.39 million to acquire the remaining interests in West Santa Fe. In addition, 2 million Lahontan shares already issued to Emergent are to be returned to the company. This is complemented by other assets, including a USD 3.5 million promissory note from Fairchild Gold, 12.5 million Fairchild shares, a 0.5% NSR royalty on the Golden Arrow Project, and additional royalties and claims in Nevada and Quebec. Lahontan views the acquisition as another step toward advancing the Santa Fe project toward production, expanding its gold and silver resources, and capitalizing on further growth opportunities in Nevada. The closing is still subject to approval by Emergent’s shareholders as well as regulatory and court approvals.

The acquisition could also position Lahontan for its next move in the US capital markets. CEO Kimberly Ann has repeatedly emphasized in the past that the US plays a central role for the company due to the investor base there and better access to capital. She is therefore aiming to list on the New York Stock Exchange. Full control over West Santa Fe, the elimination of royalties, and the consolidation of a land package spanning more than 93 km² in Walker Lane simplify and expand the company’s narrative. Combined with the mine’s construction next year, the Emergent acquisition could also improve conditions for a future initial public offering in the US.

https://youtu.be/QGRV7IfTWec?si=GHVNPooFwSnStJ6n

BASF: Analysts Assess Potential Acquisition

It is not just Lahontan where the acquisition merry-go-round is spinning. A major shakeup is brewing in the German chemical sector. BASF is exploring the acquisition of Evonik. The Ludwigshafen-based company confirmed exploratory talks with Evonik and the RAG Foundation, which holds approximately 43% of Evonik’s shares. BASF cites its goal of strengthening its core businesses, promoting profitable growth, and creating value through acquisitions as the reason for its interest. Evonik would, in particular, significantly expand BASF’s specialty chemicals business. However, nothing has been decided yet. BASF explicitly states that the progress and outcome of the talks remain open. Evonik reacted cautiously. The company confirmed a non-binding approach from BASF regarding a voluntary public tender offer for all shares, but at the same time stated that no talks are currently taking place. For now, Evonik intends to issue further statements only as required by law.

mwb research commented positively on the potential acquisition, though it noted that there are financial uncertainties. Evonik would shift BASF more strongly toward specialty chemicals, thereby reducing its dependence on the more cyclical basic chemicals business. In addition, analysts see potential synergies in procurement, production, and administration. However, the high exposure of both companies to Europe remains problematic, as weak demand, high energy costs, and structural cost pressures are weighing on competitiveness. Furthermore, with a market capitalization of around EUR 9 billion, Evonik would be a major transaction for BASF. It could strain its recently improved balance sheet and reduce its leeway for share buybacks and dividends.

From the analysts’ perspective, the price and financing are therefore crucial. Evonik is currently valued at around 6.5x EV/EBITDA for 2027, making it cheaper than BASF at about 7.7x, which generally provides a reasonable starting point. However, the acquisition would only create value if BASF does not pay too high a premium and actually realizes the expected synergies. An aggressive purchase price or a significant increase in leverage, by contrast, would weaken BASF’s investment case. Accordingly, the potential transaction is currently viewed more as an additional source of uncertainty regarding capital allocation. Analysts are maintaining a “Hold” rating and a price target of EUR 55. BASF shares have still gained a solid 12% so far this year and are currently trading around EUR 50.

Rheinmetall: Success in the US

Rheinmetall has gone from high-flyer to problem child this year. The stock of Germany’s largest defence contractor has long since fallen from its all-time high of around EUR 2,000. After it looked in the summer as though the company might at least regain the EUR 1,000 mark, the stock has been trading below that level again for several weeks and has lost nearly 40% of its value this year.

Rheinmetall is often accused of being too dependent on German defence spending and on “old and heavy” military equipment. A contract from the US demonstrates that the company is addressing both of these challenges. There, Rheinmetall has achieved another success in the future-oriented segment of autonomous military vehicles. Its US subsidiary, American Rheinmetall, is supplying 12 Mission Master SP autonomous unmanned ground vehicles and 5 amphibious marine kits to the US Marine Corps. Although the contract value of USD 7.28 million is modest, the order is strategically significant. It follows more than four years of joint testing and trials with the Marine Corps and confirms Rheinmetall’s position in the US market for autonomous land systems.

The Mission Master SP vehicles are primarily intended for autonomous logistics, expeditionary mobility, and distributed operations. The vehicles are equipped with Rheinmetall’s PATH autonomy architecture and modular payload systems. The marine kits also enable amphibious operations in coastal waters. The contract builds on extensive operational tests, live-fire trials, and user feedback, demonstrating that Rheinmetall’s autonomous systems are increasingly making the transition from testing to regular procurement.

Furthermore, the contract aligns with Rheinmetall’s long-term US strategy. American Rheinmetall is expanding its capabilities for autonomous ground vehicles in the United States and plans to establish an Advanced Land Autonomy Centre of Excellence in Maine. Among other things, PATH systems will be integrated, and vehicles will be produced and maintained there in the future. For Rheinmetall, the current contract is therefore of interest not so much because of its volume, but rather as another successful reference with the US Marine Corps and as a door opener for future larger contracts in the growing market for autonomous military systems.

Lahontan Gold is likely to continue making headlines in the coming months. The planned acquisition is another step in the company’s development. BASF’s acquisition of Evonik would be a bombshell. However, mwb rightly notes that this does not eliminate weak demand, high energy costs, and structural cost pressures. Rheinmetall remains a core investment in the European defence sector. However, the entire sector is currently struggling on the stock market.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.